000 | 01603 a2200481 4500 | ||
---|---|---|---|
005 | 20250513092836.0 | ||
264 | 0 | _c19960905 | |
008 | 199609s 0 0 eng d | ||
022 | _a0006-4971 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNelson, E L | |
245 | 0 | 0 |
_aTumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma. _h[electronic resource] |
260 |
_bBlood _cJul 1996 |
||
300 |
_a580-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aCytotoxicity, Immunologic |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Rearrangement, B-Lymphocyte |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin Idiotypes _ximmunology |
650 | 0 | 4 | _aImmunotherapy, Active |
650 | 0 | 4 | _aLife Tables |
650 | 0 | 4 | _aLymphocyte Count |
650 | 0 | 4 |
_aLymphoma, Follicular _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Proteins _ximmunology |
650 | 0 | 4 |
_aReceptors, Antigen, B-Cell _ximmunology |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aLi, X | |
700 | 1 | _aHsu, F J | |
700 | 1 | _aKwak, L W | |
700 | 1 | _aLevy, R | |
700 | 1 | _aClayberger, C | |
700 | 1 | _aKrensky, A M | |
773 | 0 |
_tBlood _gvol. 88 _gno. 2 _gp. 580-9 |
|
999 |
_c8693093 _d8693093 |